51. Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.
- Author
-
Tarlock K, Johnson D, Cornell C, Parnell S, Meshinchi S, Baker KS, and Englund JA
- Subjects
- Adult, Antifungal Agents adverse effects, Bone Diseases blood, Child, Child, Preschool, Combined Modality Therapy, Female, Follow-Up Studies, Hematologic Neoplasms microbiology, Hematologic Neoplasms therapy, Humans, Infant, Male, Prognosis, Transplant Recipients, Young Adult, Bone Diseases chemically induced, Fluorides blood, Hematologic Neoplasms complications, Hematopoietic Stem Cell Transplantation adverse effects, Periostitis chemically induced, Voriconazole adverse effects
- Abstract
Azole therapy is widely utilized in hematopoietic stem cell transplant (HCT) recipients for the treatment of aspergillus. Complications of voriconazole treatment related to its elevated fluoride content have been described in adults, including reports of symptomatic skeletal fluorosis. We review fluoride levels, clinical, and laboratory data in five pediatric HCT recipients on long-term voriconazole therapy, all found to have elevated serum fluoride levels. Two patients had toxic fluoride levels, one infant had symptoms of significant pain with movement and radiographs confirmed skeletal fluorosis. Monitoring fluoride levels in children, especially with skeletal symptoms, should be considered in patients on long-term voriconazole., (© 2014 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF